Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 310

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Insulinotropic Hormone Glucagon-Like Peptide-1 Differentiation of Human Pancreatic Islet-Derived Progenitor Cells into Insulin-Producing Cells

Open access
Abraham, E. J.·2002·Endocrinology

Abstract

Glucagon-like peptide-1 (GLP-1) is an intestinal incretin hormone, derived from the processing of proglucagon, that exerts insulinotropic actions on insulin-producing pancreatic islet beta-cells. Recently GLP-1 was shown to stimulate the growth and differentiation (neogenesis) of beta-cells and appears to do so by inducing the expression of the homeodomain protein IDX-1 (islet duodenum homeobox-1; also known as PDX-1, pancreatic and duodenal homeobox gene; and as IPF-1, insulin promoter factor), which is required for pancreas development and the expression of beta-cell-specific genes. Earlier we identified multipotential progenitor cells in the islet and ducts of the pancreas, termed nestin-positive islet-derived progenitor cells (NIPs). Here we report the expression of functional GLP-1 receptors on NIPs and that GLP-1 stimulates the differentiation of NIPs into insulin-producing cells. Furthermore, confluent NIP cultures express the proglucagon gene and secrete GLP-1. These findings suggest a model of islet development in which pancreatic progenitor cells express both GLP-1 receptors and proglucagon with the formation of GLP-1. Locally produced GLP-1 may act as an autocrine/paracrine developmental morphogen on receptors on NIPs, resulting in the activation of IDX-1 and the expression of the proinsulin gene conferring a beta-cell phenotype. GLP-1 may be an important morphogen both for the embryonic development of the pancreas and for the neogenesis of beta-cells in the islets of the adult pancreas.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.143.8.3152

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 47

  1. Kruszynska, 1996, Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus., J Invest Med, 44, 413
  2. O’Rahilly, 1997, Science, medicine, and the future. Non-insulin dependent diabetes mellitus: the gathering storm., Br Med J, 314, 955, 10.1136/bmj.314.7085.955 · DOI
  3. Ryan, 2001, Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol., Diabetes, 50, 710, 10.2337/diabetes.50.4.710 · DOI · Paper page
  4. Kieffer, 1999, The glucagon-like peptides., Endocr Rev, 20, 876, 10.1210/edrv.20.6.0385 · DOI · Paper page
  5. Drucker, 1998, Glucagon-like peptides., Diabetes, 47, 159, 10.2337/diab.47.2.159 · DOI · Paper page
  6. Nie, 2000, Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats., J Clin Invest, 105, 955, 10.1172/JCI7456 · DOI
  7. Greig, 1999, Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations., Diabetologia, 42, 45, 10.1007/s001250051111 · DOI · Paper page
  8. Stoffers, 2000, Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas., Diabetes, 49, 741, 10.2337/diabetes.49.5.741 · DOI · Paper page
  9. Xu, 1999, Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats., Diabetes, 48, 2270, 10.2337/diabetes.48.12.2270 · DOI · Paper page
  10. Zhou, 1999, Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells., Diabetes, 48, 2358, 10.2337/diabetes.48.12.2358 · DOI · Paper page
  11. Habener, 2001, Glucagonlike peptide-1 agonist stimulation of β-cell growth and differentiation., Curr Opin Endocrinol Diabetes, 8, 74, 10.1097/00060793-200104000-00004 · DOI
  12. Hui, 2001, Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells., Diabetes, 50, 785, 10.2337/diabetes.50.4.785 · DOI · Paper page
  13. Gutniak, 2001, Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes., J Intern Med, 250, 81, 10.1046/j.1365-2796.2001.00862.x · DOI
  14. Zulewski, 2001, Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes., Diabetes, 50, 521, 10.2337/diabetes.50.3.521 · DOI · Paper page
  15. Stoffers, 1997, Homeodomain protein IDX-1: a master regulator of pancreas development and insulin gene expression., Trends Endocrinol Metab, 8, 145, 10.1016/S1043-2760(97)00008-8 · DOI
  16. Edlund, 1998, Transcribing pancreas., Diabetes, 47, 1817, 10.2337/diabetes.47.12.1817 · DOI · Paper page
  17. Toma, 2001, Isolation of multipotent adult stem cells from the dermis of mammalian skin., Nat Cell Biol, 3, 778, 10.1038/ncb0901-778 · DOI · Paper page
  18. Lumelsky, 2001, Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets., Science, 292, 1389, 10.1126/science.1058866 · DOI · Paper page
  19. Daniel, 1998, Cyclical alternative exon splicing of transcription factor cyclic adenosine monophosphate response element-binding protein (CREB) messenger ribonucleic acid during rat spermatogenesis., Endocrinology, 139, 3721, 10.1210/endo.139.9.6174 · doi:10.1210/endo.139.9.6174
  20. Lu, 1997, Pancreatic β-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein β. Inhibitory interactions with basic helix-loop-helix transcription factor E47., J Biol Chem, 272, 28349, 10.1074/jbc.272.45.28349 · DOI
  21. Stoffers, 1998, Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein., J Clin Invest, 102, 232, 10.1172/JCI2242 · DOI
  22. Miller, 1994, IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene., EMBO J, 13, 1145, 10.1002/j.1460-2075.1994.tb06363.x · DOI · Paper page
  23. Schreiber, 1989, Rapid detection of octamer binding proteins with ‘mini-extracts,’ prepared from a small number of cells., Nucleic Acids Res, 17, 6419, 10.1093/nar/17.15.6419 · DOI · Paper page
  24. Holz, 1993, Pancreatic β-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7–37)., Nature, 361, 362, 10.1038/361362a0 · DOI · Paper page
  25. Weir, 1989, Glucagon like peptide I (7–37) actions on endocrine pancreas., Diabetes, 38, 338, 10.2337/diab.38.3.338 · DOI · Paper page
  26. Jonsson, 1994, Insulin-promoter-factor 1 is required for pancreas development in mice., Nature, 371, 606, 10.1038/371606a0 · DOI · Paper page
  27. Ferber, 2000, Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia., Nat Med, 6, 568, 10.1038/75050 · DOI · Paper page
  28. Josephson, 1998, POU transcription factors control expression of CNS stem cell-specific genes., Development, 125, 3087, 10.1242/dev.125.16.3087 · DOI
  29. Hussain, 1997, POU domain transcription factor brain 4 confers pancreatic α-cell-specific expression of the proglucagon gene through interaction with a novel proximal promoter G1 element., Mol Cell Biol, 17, 7186, 10.1128/MCB.17.12.7186 · DOI
  30. Skoglund, 2000, Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element., Diabetes, 49, 1156, 10.2337/diabetes.49.7.1156 · DOI
  31. Montrose-Rafizadeh, 1999, Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells., Endocrinology, 140, 1132, 10.1210/endo.140.3.6550 · doi:10.1210/endo.140.3.6550 · Paper page
  32. Garcia-Flores, 2001, Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7–36) amide on insulin release by pancreatic islets during rat ontogenic development., Eur J Biochem, 268, 514, 10.1046/j.1432-1327.2001.01865.x · DOI
  33. Gribble, 2000, Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from β cells and extrapancreatic tissues., Metabolism, 49, 3, 10.1053/meta.2000.17822 · DOI
  34. Ashcroft, 2000, Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels., J Diabetes Complications, 14, 192, 10.1016/S1056-8727(00)00081-7 · DOI
  35. Seufert, 1998, Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein β and transactivator islet duodenum homeobox-1 in rat pancreatic β cells during the development of diabetes mellitus., J Clin Invest, 101, 2528, 10.1172/JCI2401 · DOI
  36. Donath, 1999, Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes., Diabetes, 48, 738, 10.2337/diabetes.48.4.738 · DOI · Paper page
  37. Federici, 2001, High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program., Diabetes, 50, 1290, 10.2337/diabetes.50.6.1290 · DOI · Paper page
  38. Maedler, 2001, Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets., Diabetes, 50, 1683, 10.2337/diabetes.50.8.1683 · DOI · Paper page
  39. Slack, 1995, Developmental biology of the pancreas., Development, 121, 1569, 10.1242/dev.121.6.1569 · DOI · Paper page
  40. Al-Abdullah, 2000, Neogenesis of pancreatic endocrine cells in copper-deprived rat models., Pancreas, 21, 63, 10.1097/00006676-200007000-00053 · DOI
  41. Jones, 2001, β-Cell neogenesis in type 2 diabetes, Diabetes, 50, S186, 10.2337/diabetes.50.2007.S186 · DOI
  42. Bernard, 1999, Neogenesis vs. apoptosis as main components of pancreatic β cell mass changes in glucose-infused normal and mildly diabetic adult rats., FASEB J, 13, 1195, 10.1096/fasebj.13.10.1195 · DOI
  43. Mashima, 1996, Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells., J Clin Invest, 97, 1647, 10.1172/JCI118591 · DOI · Paper page
  44. Wang, 2001, Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiation., J Biol Chem, 276, 25279, 10.1074/jbc.M101233200 · DOI
  45. Hussain, 2001, Brn-4 transcription factor expression targeted to the early developing mouse pancreas induces ectopic glucagon gene expression in insulin-producing β-cells., J Biol Chem, 277, 16028, 10.1074/jbc.M107124200 · doi:10.1074/jbc.m107124200
  46. Teitelman, 1993, Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide., Development, 118, 1031, 10.1242/dev.118.4.1031 · DOI · Paper page
  47. Polak, 2000, Early pattern of differentiation in the human pancreas., Diabetes, 49, 225, 10.2337/diabetes.49.2.225 · DOI · Paper page

Cited by

See all 310

Metadata

Authors
Abraham, E. J.
Venue
Endocrinology
Published
2002-08-01
Volume
143
Issue
8
Pages
3152-3161
ISSN
0013-7227 (ISSN-L)
OpenAlex
W2156959752
Cited by
310
References
3
FWCI
29.04
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulinotropic Hormone Glucagon-Like Peptide-1 Differentiation of Human Pancreatic Islet-Derived Progenitor Cells into Insulin-Producing Cells. https://app.cochat.ai/papers/10.1210/en.143.8.3152
The paper
Abraham, E. J. (2002). Insulinotropic Hormone Glucagon-Like Peptide-1 Differentiation of Human Pancreatic Islet-Derived Progenitor Cells into Insulin-Producing Cells. Endocrinology. https://doi.org/10.1210/en.143.8.3152

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.